Hsa_circ_0007059 promotes apoptosis and inflammation in cardiomyocytes during ischemia by targeting microRNA-378 and microRNA-383

References

• Fiedler J, Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol. 2013;33(2):201–205.
   PubMed Web of Science ®Google Scholar
• Thind GS, Agrawal PR, Hirsh B, et al. Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations. Future Cardiol. 2015;11(1):61–76.
   PubMed Web of Science ®Google Scholar
• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proceedings of the National Academy of Sciences. 1976;73( 11):3852–3856.
   Google Scholar
• Wang PL, Bao Y, Yee M-C, et al. Circular RNA is expressed across the eukaryotic tree of life. PloS one. 2014;9:3.
   Web of Science ®Google Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453.
   PubMed Web of Science ®Google Scholar
• Geng -H-H, Li R, Su Y-M, et al. The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression. PloS one. 2016;11(3):3.
   Web of Science ®Google Scholar
• Zhou L-Y, Zhai M, Huang Y, et al. The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/FAM65B pathway. Cell Death Differ. 2019;26(7):1299–1315.
   PubMed Web of Science ®Google Scholar
• Wang K, Gan T-Y, Li N, et al. Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression. Cell Death Differ. 2017;24(6):1111–1120.
   PubMed Web of Science ®Google Scholar
• Gao S, Yu Y, Liu L, et al. Circular RNA hsa_circ_0007059 restrains proliferation and epithelial-mesenchymal transition in lung cancer cells via inhibiting microRNA-378. Life Sci. 2019;233:116692.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol. 2016;94:107–121.
   PubMed Web of Science ®Google Scholar
• Fang J, Song X-W, Tian J, et al. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis. 2012;17(4):410–423.
   PubMed Web of Science ®Google Scholar
• Xu D, Ma P, Gao G, et al. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells. Tumor Biol. 2015;36(10):7743–7753.
   PubMedGoogle Scholar
• Pei L, Meng S, Yu W, et al. Inhibition of microRNA-383 ameliorates injury after focal cerebral ischemia via targeting PPARγ. Cell Physiol Biochem. 2016;39(4):1339–1346.
   PubMedGoogle Scholar
• Lian Z, Lv FF, Yu J, et al. The anti‐inflammatory effect of microRNA‐383‐3p interacting with IL1R2 against homocysteine‐induced endothelial injury in rat coronary arteries. J Cell Biochem. 2018;119(8):6684–6694.
   PubMed Web of Science ®Google Scholar
• Hang P, Sun C, Guo J, et al. BDNF-mediates Down-regulation of MicroRNA-195 Inhibits Ischemic Cardiac Apoptosis in Rats. Int J Biol Sci. 2016;12(8):979–989.
   PubMed Web of Science ®Google Scholar
• Huang W, Tian SS, Hang PZ, et al. Combination of microRNA-21 and microRNA-146a Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction in Mice. Mol Ther Nucleic Acids. 2016;5:e296.
   PubMedGoogle Scholar
• Friedman RC, Farh KK-H, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.
   PubMed Web of Science ®Google Scholar
• Ong S-B, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87.
   PubMed Web of Science ®Google Scholar
• Misra MK, Sarwat M, Bhakuni P, et al. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit. 2009 Oct;15(10):Ra209–219.
   PubMed Web of Science ®Google Scholar
• Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet. 2011 Aug 20;378(9792):704–712.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang H, Li J. Inflammation and inflammatory cells in myocardial infarction and reperfusion injury: a double-edged sword. Clin Med Insights Cardiol. 2016;10:S33164. CMC.
   Google Scholar
• Bezerra OC, França CM, Rocha JA, et al. Cholinergic stimulation improves oxidative stress and inflammation in experimental myocardial infarction. Sci Rep. 2017;7(1):1–12.
   PubMedGoogle Scholar
• Forteza MJ, Trapero I, Hervas A, et al. Apoptosis and mobilization of lymphocytes to cardiac tissue is associated with myocardial infarction in a reperfused porcine model and infarct size in post-PCI patients. Oxid Med Cell Longev. 2018;2018.
   Web of Science ®Google Scholar
• Frangogiannis NG. Pathophysiology of Myocardial Infarction. Compr Physiol. 2015 Sep 20;5(4):1841–1875.
   PubMed Web of Science ®Google Scholar
• Frantz S, Nahrendorf M. Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res. 2014 May 1;102(2):240–248.
   PubMed Web of Science ®Google Scholar
• Ji RC. The role of lymphangiogenesis in cardiovascular diseases and heart transplantation. Heart Fail Rev. 2021 Nov;4.
   Web of Science ®Google Scholar
• Lodrini AM, Goumans MJ. Cardiomyocytes Cellular Phenotypes After Myocardial Infarction. Front Cardiovasc Med. 2021;8:750510.
   PubMedGoogle Scholar
• Wen Y-C, Hsiao F-Y, Chan KA, et al. Acute respiratory infection and use of nonsteroidal anti-inflammatory drugs on risk of acute myocardial infarction: a nationwide case-crossover study. J Infect Dis. 2017;215(4):503–509.
   PubMed Web of Science ®Google Scholar
• Huang S, Frangogiannis NG. Anti‐inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br J Pharmacol. 2018;175(9):1377–1400.
   PubMed Web of Science ®Google Scholar
• Libby P, Maroko PR, Bloor CM, et al. Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest. 1973;52(3):599–607.
   PubMed Web of Science ®Google Scholar
• Boulakh L, Gislason GH. Treatment with non-steroidal anti-inflammatory drugs in patients after myocardial infarction - a systematic review. Expert Opin Pharmacother. 2016 Jul;17(10):1387–1394.
   PubMed Web of Science ®Google Scholar
• Chen QM. Nrf2 for cardiac protection: pharmacological options against oxidative stress. Trends Pharmacol Sci. 2021 Sep;42(9):729–744.
   PubMed Web of Science ®Google Scholar
• Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem. 2009;284(43):29514–29525.
   PubMed Web of Science ®Google Scholar
• Shi B, Guo Y, Wang J, et al. Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction. BMC Cardiovasc Disord. 2010;10(1):11.
   PubMedGoogle Scholar
• Boštjančič E, Zidar N, Glavač D. MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers. 2009;27(6):255–268.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang D, Xie P, et al. MiR-106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction. Cell Physiol Biochem. 2012;29(5–6):851–862.
   PubMedGoogle Scholar
• Huang W, Tian -S-S, Hang P-Z, et al. Combination of microRNA-21 and microRNA-146a attenuates cardiac dysfunction and apoptosis during acute myocardial infarction in mice. Mol Ther Nucleic Acids. 2016;5:e296.
   PubMedGoogle Scholar